RVL Pharmaceuticals News and Activities

RVL Pharmaceuticals is a company listed under the stock ticker RVLP (US).

View the org chart displaying its 16 main executives

Most searched biographies at RVL Pharmaceuticals

• Lori Deo, Chief Executive Officer
• Jessica Solomon, Chief Human Resources Officer
• Raymond Douglas, Head of Scientific Affairs

Popular executive movements at RVL Pharmaceuticals

• Amy Shah has joined the company as Chief Growth Officer  (posted on November 24 2025).
• Lori Deo has joined the company as Chief Executive Officer  (posted on November 24 2025).

Create your alert
to follow the executive moves at RVL Pharmaceuticals.

RVL Pharmaceuticals has 1,920 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Catalyst Pharmaceuticals, listed under ticker CPRX, has been delisted. (posted on July 13 2026).
• Angelini Pharma has acquired Catalyst Pharmaceuticals (posted on July 13 2026).
• Vertex Pharmaceuticals has announced the acquisition of Crinetics Pharmaceuticals  (posted on July 7 2026).

Popular contacts in Pharmaceuticals

• David Ricks - President, Chief Executive Officer and Chairman of the Board at Eli Lilly
• Richard Saynor - Chief Executive Officer at Sandoz
• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson

Learn more about the Pharmaceuticals industry

Press releases by RVL Pharmaceuticals

• Osmotica Pharmaceuticals plc.
• RVL Pharmaceuticals plc to Discuss Second Quarter 2022 Financial Results and Provide Commercial Update | RVL Pharmaceuticals
• RVL Pharmaceuticals plc to Discuss Second Quarter 2022 Financial Results and Provide Commercial Update | RVL Pharmaceuticals
• Press Releases | RVL Pharmaceuticals
• RVL Pharmaceuticals plc Announces Preliminary Second Quarter 2022 UPNEEQ® Net Product Sales Results | RVL Pharmaceuticals
• Press Releases | RVL Pharmaceuticals
• RVL Pharmaceuticals plc Announces Preliminary Second Quarter 2022 UPNEEQ® Net Product Sales Results | RVL Pharmaceuticals
• RVL Pharmaceuticals plc Announces Result of Proposal 3 at Annual General Meeting | RVL Pharmaceuticals
• RVL Pharmaceuticals plc Announces Result of Proposal 3 at Annual General Meeting | RVL Pharmaceuticals
• RVL Pharmaceuticals plc to Present at Upcoming Conferences | RVL Pharmaceuticals
• View more press releases Close

Social media about RVL Pharmaceuticals

• RVL Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• RVL Pharmaceuticals on LinkedIn, X (Twitter) & YouTube